Inspire Advisors LLC bought a new position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 23,482 shares of the real estate investment trust's stock, valued at approximately $475,000.
Several other institutional investors have also recently made changes to their positions in the company. Machina Capital S.A.S. lifted its holdings in shares of Healthpeak Properties by 62.8% in the first quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust's stock worth $751,000 after buying an additional 14,336 shares in the last quarter. Douglas Lane & Associates LLC increased its stake in shares of Healthpeak Properties by 8.5% in the first quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock worth $56,471,000 after buying an additional 218,395 shares during the period. Cambridge Investment Research Advisors Inc. increased its stake in shares of Healthpeak Properties by 6.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock worth $7,229,000 after buying an additional 23,135 shares during the period. Ibex Wealth Advisors purchased a new position in Healthpeak Properties during the 1st quarter valued at $5,056,000. Finally, Vert Asset Management LLC increased its position in Healthpeak Properties by 6.9% during the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock valued at $6,574,000 after purchasing an additional 20,924 shares during the period. Institutional investors own 93.57% of the company's stock.
Insider Buying and Selling
In other news, CEO Scott M. Brinker bought 2,930 shares of the stock in a transaction dated Thursday, July 31st. The stock was purchased at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the transaction, the chief executive officer owned 210,416 shares of the company's stock, valued at $3,589,696.96. The trade was a 1.41% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Tommy G. Thompson bought 5,777 shares of the stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the transaction, the director directly owned 144,290 shares in the company, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 20,030 shares of company stock valued at $346,519 over the last quarter. Corporate insiders own 0.23% of the company's stock.
Analysts Set New Price Targets
DOC has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, June 2nd. Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Argus restated a "buy" rating and set a $25.00 target price on shares of Healthpeak Properties in a report on Tuesday, April 29th. Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the company an "outperform" rating in a report on Wednesday. Finally, Scotiabank cut shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their target price for the company from $21.00 to $19.00 in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, Healthpeak Properties has an average rating of "Moderate Buy" and an average target price of $23.00.
Check Out Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Stock Performance
DOC traded up $0.01 during midday trading on Friday, hitting $16.95. 3,712,348 shares of the company traded hands, compared to its average volume of 5,932,029. Healthpeak Properties, Inc. has a 52 week low of $16.64 and a 52 week high of $23.26. The firm has a market capitalization of $11.78 billion, a PE ratio of 70.65, a price-to-earnings-growth ratio of 2.20 and a beta of 1.03. The company's 50-day moving average is $17.69 and its 200 day moving average is $18.77. The company has a quick ratio of 1.35, a current ratio of 1.28 and a debt-to-equity ratio of 1.06.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same period last year, the firm posted $0.45 EPS. The company's revenue was down .2% on a year-over-year basis. On average, research analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Friday, September 19th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 7.2%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's dividend payout ratio is currently 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.